CS191254B2 - Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza - Google Patents

Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza

Info

Publication number
CS191254B2
CS191254B2 CS75255A CS25575A CS191254B2 CS 191254 B2 CS191254 B2 CS 191254B2 CS 75255 A CS75255 A CS 75255A CS 25575 A CS25575 A CS 25575A CS 191254 B2 CS191254 B2 CS 191254B2
Authority
CS
Czechoslovakia
Prior art keywords
neuraminidazoic
hemagglutinic
isolation
component
virus influenza
Prior art date
Application number
CS75255A
Other languages
English (en)
Inventor
Helmut Bachmayer
Gerhard Schmidt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CS191254B2 publication Critical patent/CS191254B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
CS75255A 1974-01-14 1975-01-14 Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza CS191254B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (cs) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
CS191254B2 true CS191254B2 (en) 1979-06-29

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
CS75255A CS191254B2 (en) 1974-01-14 1975-01-14 Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza

Country Status (27)

Country Link
JP (2) JPS58407B2 (cs)
AT (1) AT345449B (cs)
AU (1) AU500250B2 (cs)
BE (1) BE824372A (cs)
CA (1) CA1049406A (cs)
CH (1) CH589453A5 (cs)
CS (1) CS191254B2 (cs)
DD (1) DD116239A5 (cs)
DE (1) DE2500785B2 (cs)
DK (1) DK140003B (cs)
ES (1) ES433759A1 (cs)
FI (1) FI54053C (cs)
FR (1) FR2257305B1 (cs)
GB (1) GB1498261A (cs)
HK (1) HK56380A (cs)
HU (1) HU173920B (cs)
IE (1) IE40794B1 (cs)
IL (1) IL46426A (cs)
MY (1) MY8100204A (cs)
NL (1) NL166622C (cs)
NO (1) NO143128C (cs)
PH (1) PH14458A (cs)
PL (1) PL93689B1 (cs)
SE (1) SE427238B (cs)
SU (1) SU616997A3 (cs)
YU (1) YU41289B (cs)
ZA (1) ZA75259B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
PT2301572E (pt) * 2005-11-01 2014-12-22 Novartis Vaccines & Diagnostic Vacinas virais derivadas de células com níveis baixos de adn celular residual
RU2496519C2 (ru) * 2007-08-28 2013-10-27 Бакстер Интернэшнл Инк. Способ получения препарата, содержащего вирусные антигены, и применение препарата
CA2930634C (en) 2013-11-15 2023-05-09 Novartis Ag Removal of influenza nuclear protein (np) from influenza virus preparations

Also Published As

Publication number Publication date
FR2257305B1 (cs) 1982-03-19
DE2500785C3 (cs) 1980-09-11
NL166622C (nl) 1981-09-15
HU173920B (hu) 1979-09-28
JPS56127319A (en) 1981-10-06
IL46426A0 (en) 1975-04-25
MY8100204A (en) 1981-12-31
YU41289B (en) 1987-02-28
FR2257305A1 (cs) 1975-08-08
FI750014A (cs) 1975-07-15
AU7730575A (en) 1976-07-15
DK140003B (da) 1979-06-05
FI54053C (fi) 1978-10-10
NL166622B (nl) 1981-04-15
DD116239A5 (cs) 1975-11-12
NL7500301A (nl) 1975-07-16
YU5875A (en) 1984-04-30
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
ATA21475A (de) 1978-01-15
JPS58407B2 (ja) 1983-01-06
DK1475A (cs) 1975-09-01
SU616997A3 (ru) 1978-07-25
AT345449B (de) 1978-09-11
PH14458A (en) 1981-07-29
DE2500785B2 (de) 1980-01-03
JPS50100224A (cs) 1975-08-08
NO143128B (no) 1980-09-15
SE427238B (sv) 1983-03-21
ES433759A1 (es) 1977-02-16
CA1049406A (en) 1979-02-27
DK140003C (cs) 1979-10-29
AU500250B2 (en) 1979-05-17
BE824372A (fr) 1975-07-14
SE7500130L (cs) 1975-07-15
IE40794L (en) 1975-07-14
FI54053B (fi) 1978-06-30
NO750031L (cs) 1975-08-11
IE40794B1 (en) 1979-08-15
JPS6035326B2 (ja) 1985-08-14
HK56380A (en) 1980-10-16
GB1498261A (en) 1978-01-18
IL46426A (en) 1978-01-31
DE2500785A1 (de) 1975-07-31
PL93689B1 (cs) 1977-06-30
CH589453A5 (cs) 1977-07-15

Similar Documents

Publication Publication Date Title
HU171420B (hu) Sposob poluchenija proizvodnykh sul'fonamido-piridina i piridin-tiadiazina
DK356075A (da) Fremgangsmade til fremstilling af 1-oxacephemer samt mellemprodukter dertil
SE419605B (sv) Forfarande for framstellning av undertrycksformad gjutform
IE41786L (en) Process for the preparation of ketones
CS191254B2 (en) Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza
ZA757118B (en) Process for the preparation of addition agents
ZA752394B (en) Process for the isolation of gama-l-glutamyl-taurine
EG11831A (en) Process for the preparation of 2-nitrobenzaldehyde and 2-nitrobenzylidenechloride
IL48062A0 (en) Process for the preparation of metasubstituted halogenophenols
CH613683A5 (en) Process for the preparation of secoprostaglandins
EG11784A (en) Process for the preparation of octenitrile compounds and compounds obtained thereby
PH11610A (en) Process for the preparation of 2-nitrobenzaldehyde
ZA752148B (en) Process and equipment for the condensation of steam
ZM11375A1 (en) Process for the preparation of poly-(-n-alkyliminoalanes)
ZA75976B (en) Process for the preparation of cis-vincamine
CH611273A5 (en) Process for the preparation of novel 3-oxocyclohex-1-en-1-yl- ureas
CH614216A5 (en) Process for the preparation of deoxyparomomycin and dideoxyparomomycin
CH613445A5 (en) Process for the preparation of novel N-(p-fluorobenzoylpropyl)-4-piperidylamides
GB1485916A (en) Process for the preparation of propargyl amines and products obtained thereby
IL47243A0 (en) Process for the preparation of 4-hydroxypyrimidines
CH614443A5 (en) Process for the preparation of 1-thiadiazolyl-6-acyloxytetrahydropryrimidinones
IL48633A (en) Process for the preparation of trichlorothiazole
GB1518104A (en) Process for the preparation of 2-hydrocarbylglycerols
CH613693A5 (en) Process for the preparation of trisaminopyridines
ZA753165B (en) Process for the preparation of monoacyloxy (or aroyl-oxy) alkylenecarbonates and products obtained